v3.26.1
Condensed consolidated statements of convertible preferred stock and stockholders' deficit (unaudited) - USD ($)
Total
Series A-1 Convertible Preferred Stock
Series A-2 Convertible Preferred Stock
Series A-2 (NV) Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Balance at beginning of period at Dec. 31, 2024 $ (218,772,000)           $ 941,000   $ (219,713,000)
Balance at beginning of period, shares at Dec. 31, 2024           1      
Balance at beginning of period, convertible preferred stock at Dec. 31, 2024   $ 294,358,000 $ 84,501,000 $ 11,447,000          
Balance at beginning of period, convertible preferred stock, shares at Dec. 31, 2024   30,000,000 4,968,789 708,814          
Stock-based compensation expense 1,523,000           1,523,000    
Unrealized loss on marketable securities (6,000)             $ (6,000)  
Net Income (Loss) (17,983,000)               (17,983,000)
Balance at end of period at Mar. 31, 2025 (235,238,000)           2,464,000 (6,000) (237,696,000)
Balance at end of period, shares at Mar. 31, 2025           1      
Balance at end of period, convertible preferred stock at Mar. 31, 2025   $ 294,358,000 $ 84,501,000 $ 11,447,000          
Balance at end of period, convertible preferred stock, shares at Mar. 31, 2025   30,000,000 4,968,789 708,814          
Balance at beginning of period at Dec. 31, 2025 (356,458,000)           11,981,000 229,000 (368,668,000)
Balance at beginning of period, shares at Dec. 31, 2025           19,048      
Balance at beginning of period, convertible preferred stock at Dec. 31, 2025 $ 992,363,123 $ 294,357,583 $ 84,501,000 $ 11,447,000 $ 602,057,535        
Balance at beginning of period, convertible preferred stock, shares at Dec. 31, 2025 78,762,142 30,000,000 4,968,789 708,814 43,084,539        
Exercise of stock options (in shares) 10,905         10,905      
Exercise of stock options $ 57,000           57,000    
Stock-based compensation expense 3,939,000           3,939,000    
Unrealized loss on marketable securities (761,000)             (761,000)  
Net Income (Loss) (78,865,000)               (78,865,000)
Balance at end of period at Mar. 31, 2026 (432,088,000)           $ 15,977,000 $ (532,000) $ (447,533,000)
Balance at end of period, shares at Mar. 31, 2026           29,953      
Balance at end of period, convertible preferred stock at Mar. 31, 2026 $ 992,363,123 $ 294,357,583 $ 84,501,000 $ 11,447,000 $ 602,057,535        
Balance at end of period, convertible preferred stock, shares at Mar. 31, 2026 78,762,142 30,000,000 4,968,789 708,814 43,084,539